3,491.90
+3.77%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Privi Speciality Chemicals
Its shares trade on NSE under the ticker PRIVISCL.NS. It has been listed since 8 May 2015. In the fiscal year to 31 March 2026, it reported revenue of ₹25.64bn and net income of ₹3.28bn. At that date it held total assets of ₹31.70bn and shareholders' equity of ₹14.12bn.
Privi Speciality Chemicals Ltd. engages in the manufacture, supply and export of aroma and fragrance chemicals. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2015-05-08. The firm's flagship products include Dihydromyrcenol, Amber Fleur and Pine Oil. The company also develops and produces custom-made aroma chemicals as per the specific requirement of the customers. Its products are used in home care, personal care, fabric care, oral care, fine fragrances and food products, such as beverages, snacks, dairy products and sweets, among others. The firm's manufacturing units are located at Mahad, Maharashtra and Jhagadia, Gujarat. The firm has a total production capacity of over 55,000 tons per annum (TPA) spread across Amber fleur, Acetates, Dihydromyrcenol, Ionones, Nitriles, Sandalwood derivatives and Speciality chemicals and a Crude Sulphate Turpentine (CST)/Gum Turpentine Oil (GTO) capacity of over 36,000 TPA. Its subsidiaries include Privi Biotechnologies Private Limited and Privi Speciality Chemicals USA Corporation.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 8 May 2015
- Employees
- 725
- Website
- privi.com ↗
Leadership
Pay as last reported
- Mr. Mahesh BabaniExecutive Chairman of the Board, Managing Director, since 2017₹42.0m
- Mr. R. RajanPresident₹20.3m
- Mr. Narayan IyerChief Financial Officer₹10.4m
- Ms. Ashwini ShahCompany Secretary and Compliance Officer
- Mr. Bhaktavatsala RaoExecutive Director, since 2017₹2.4m
- Mrs. Priyamvada BhumkarNon-Executive Woman Independent Director₹200,000
- Mr. Hemang GandhiNon-Executive Independent Director, since 2023₹500,000
- Mr. Anurag SuranaNon-Executive Independent Director₹600,000
- Mr. Naresh TejwaniNon-Executive Independent Director₹200,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 43
- Environment
- 22
- Social
- 26
- Governance
- 82
- Direct emissions (scope 1)
- 178,619.21 t
- Energy emissions (scope 2)
- 38,512.5 t
- Value chain emissions (scope 3)
- 223,916.77 t
- Women in the workforce
- 6.34%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Privi Speciality Chemicals Ltd. has a production capacity of over 55,000 tons per annum for specialty chemicals.
- The company's flagship products include Dihydromyrcenol, Amber Fleur, and Pine Oil for various industries.
- Privi Speciality Chemicals USA Corporation supports international market expansion and customer needs.
Weaknesses
- The company's manufacturing units are located in Mahad, Maharashtra, and Jhagadia, Gujarat, limiting geographical reach.
- Privi Biotechnologies Private Limited is a subsidiary with limited public information on its operations.
- The firm's production capacity for Crude Sulphate Turpentine is over 36,000 TPA, which may not meet growing demand.
Opportunities
- The growing demand for aroma and fragrance chemicals in home care and personal care sectors presents opportunities.
- Expanding into new markets for custom-made aroma chemicals can increase revenue streams.
- The company's presence in the Indian market with 725 employees supports scalability and growth.
Threats
- Competition from other chemical manufacturers in the Materials sector could impact market share.
- Fluctuations in raw material costs may affect production efficiency and profitability.
- The company's reliance on specific product lines like Dihydromyrcenol could lead to market vulnerability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.